Gary D. Rifkin
- Infectious Diseases top 2%
- Epidemiology top 10%
- Critical Care and Intensive Care Medicine top 5%
- Clinical Biochemistry top 5%
- Gastroenterology top 5%
- Co-authors
- Robert FeketyF. Robert FeketyJoseph SilvaR. Bradley SackMaría AllóJohn R. ArmstrongHetty WaskinJack R. Ebright
- Topics
- Clostridium difficile and Clostridium perfringens research (11 papers)Bacterial Identification and Susceptibility Testing (7 papers)Microscopic Colitis (4 papers)
- Partner nations
- United States
In The Last Decade
Gary D. Rifkin
15 papers receiving 645 citations
Peers
Comparison fields: 5 of 54
- Infectious Diseases 643
- Epidemiology 301
- Critical Care and Intensive Care Medicine 95
- Clinical Biochemistry 75
- Gastroenterology 71
Countries citing papers authored by Gary D. Rifkin
This map shows the geographic impact of Gary D. Rifkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Rifkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Rifkin more than expected).
Fields of papers citing papers by Gary D. Rifkin
This network shows the impact of papers produced by Gary D. Rifkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Rifkin. The network helps show where Gary D. Rifkin may publish in the future.
Co-authorship network of co-authors of Gary D. Rifkin
This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Rifkin. A scholar is included among the top collaborators of Gary D. Rifkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Rifkin. Gary D. Rifkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 90 | |
| 2 | 1 | |
| 3 | 21 | |
| 4 | 26 | |
| 5 | 1 | |
| 6 | 60 | |
| 7 | 26 | |
| 8 | 54 | |
| 9 | 107 | |
| 10 | Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. | 42 |
| 11 | 23 | |
| 12 | 9 | |
| 13 | 49 | |
| 14 | 46 | |
| 15 | 191 |
About Gary D. Rifkin
Gary D. Rifkin is a scholar working on Clinical Biochemistry, Infectious Diseases and Pharmacology, having authored 15 papers that have together received 746 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (11 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Microscopic Colitis (4 papers). The work is most often cited by research in Infectious Diseases (643 citations), Critical Care and Intensive Care Medicine (95 citations) and Gastroenterology (71 citations). Gary D. Rifkin has collaborated with scholars based in United States. Frequent co-authors include Robert Fekety, F. Robert Fekety, Joseph Silva, R. Bradley Sack, María Alló, John R. Armstrong, Hetty Waskin, Jack R. Ebright, R. Browne and James M. Hughes. Their work appears in journals such as The Lancet, Gastroenterology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.